NPPA recommends Sun Pharma’s Budesonide IP 9mg price
The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of Budesonide IP 9 mg for Sun Pharmaceutical Industries Ltd. (manufacturer and marketer) at Rs. 40.17 per tablet excluding GST.
The recommendation has been made by the Multidisciplinary Committee of Experts at its 30th meeting, held on 19.04.2021.
In the latest Multidisciplinary Committee meeting, the committee noted the reply received from the Office of Central Drugs Standard Control Organization (CDCSO) regarding the retail price fixation under Para 5 of DPCO, 2013 for each film-coated extended-release tablet containing Budesonide IP 9mg manufactured and marketed by Sun Pharma.
Recent Posts
Mounjaro Launched in India: Price & Impact on Diabetes and Obesity
Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…
Shocking Rabies Case in Greater Noida Challenges Common Misconceptions
A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…
Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health
The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…
Experts Warn of Global Threat from Chronic Wasting Disease
Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…
CDC Reschedules Vaccine Advisory Meeting to April 15-16
The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…
India’s Specialty Chemicals Rebound, Pharma Exports Surge
India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…